PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 139 |
| PubMedID- 20934769 | Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24627825 | Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 20580779 | Our results suggested that incorporation of almonds into a healthy diet has beneficial effects on adiposity, glycemic control, and the lipid profile, thereby potentially decreasing the risk for cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26557879 | Although aspirin has been in clinical use for more than a century, there is still much to be learned about its future uses, particularly in cancer and in patients who are at particularly high risk of cardio- and cerebrovascular diseases—such as those with diabetes mellitus and long-term survivors of hiv infection. |
| PubMedID- 25325279 | Many studies have reported postprandial hyperglycemia as a major cause of adverse cardiovascular disease in patients with diabetes mellitus [23]. |
| PubMedID- 24172142 | Furthermore, there was a strong increase in the proportion of patients between 40 and 70 years suffering from cardiovascular diseases in combination with hyperlipidemia and/or diabetes mellitus. |
| PubMedID- 21854817 | Subjects with diabetes mellitus, evidence of myocardial infarction or cerebrovascular disease were excluded from the study. |
| PubMedID- 20550659 | The action to control cardiovascular risk in diabetes (accord) study investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease [1]. |
| PubMedID- 21785619 | A therapeutic effect of myricetin in patients with cardiovascular diseases associated with diabetes mellitus has also been reported [1, 2]. |
| PubMedID- 22093212 | Background: more intensive glycemic control reduces the risk of microvascular disease in patients with diabetes mellitus but has not been proven to reduce the risk of macrovascular events such as myocardial infarction and stroke. |
| PubMedID- 22440125 | Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus. |
| PubMedID- 25400702 | Aim: gestational diabetes mellitus (gdm) is associated with cardiovascular diseases; however, the relationship between epicardial fat thickness (eft) and gdm remains unclear. |
| PubMedID- 20415560 | Vitamin e reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. |
| PubMedID- 22994940 | Our empirical strategy starts with a basic model construct (model 1) that uses control variables such as age, sex, previously diagnosed disease, and health problems (diabetes mellitus, risk of vascular disease, vascular disease, musculoskeletal disease, digestive disease, mental illness, other diseases, and report of an accident in the last 12 months). |
| PubMedID- 21501602 | Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. |
| PubMedID- 22665334 | As an example, cpgs for cardiovascular diseases in diabetes mellitus have been developed.24 these cpgs contain detailed practical instructions for management of cardiovascular diseases in diabetic patients.24 some studies have reported that cpgs can improve the health outcomes of patients in terms of in-hospital mortality or los and concluded that cpgs were a significant independent predictor of clinical outcomes of patients.25,26 therefore, we think that the preparation and institution of cpgs for bleeding peptic ulcers with comorbid diabetes mellitus would be a promising policy implementation for improving the short-term clinical outcomes of these patients. |
| PubMedID- 26318399 | Association between cetp gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease. |
| PubMedID- 25018969 | Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 24278703 | Finally, the results of the accord trial showed that the combination of fenofibrate and simvastatin does not reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus, as compared with statin monotherapy [78]; only subgroups of patients with dyslipidemia seem to benefit from fibrate therapy. |
| PubMedID- 20977287 | However, although antiplatelet therapy with low-dose aspirin has been reported to prevent vascular events in high-risk patients with cardiovascular disease, recent studies in patients with pad or diabetes mellitus have failed to support the efficacy of aspirin in preventing vascular events in these patient populations. |
| PubMedID- 20877687 | Endothelial dysfunction is a major contributor to the pathogenesis of vascular disease in diabetes mellitus patients and has recently received increased attention. |
| PubMedID- 22798707 | In diabetes mellitus complicated by cardiovascular disease, insulin resistance and abnormal blood lipid concentrations play an important role. |
| PubMedID- 25279360 | Introduction: diabetes mellitus is associated with cardiovascular disease. |
| PubMedID- 23745805 | Micrornas: biomarkers for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 21655762 | Concomitant with the clinical improvement in cp, a reduction was observed in the serum levels of il-6 and us-crp, both of which are markers of the systemic inflammatory response, in agreement with the results of other publications.10,13,20,21 considering that chronic inflammation is a risk factor for atherosclerotic cardiovascular disease in patients with hypertension and diabetes mellitus, the main causes of ckd, it is plausible that the immediate diagnosis of cp followed by pt should constitute an important preventive measure in the course of ckd in the everyday clinic. |
| PubMedID- 22430605 | In view of the high incidence of macrovascular diseases in patients with type 2 diabetes mellitus and microalbuminuria, the study evaluates the association of microalbuminuria with fasting plasma apo b48 levels, a marker of the residual presence of intestinally derived trls lipoproteins, thought to be highly atherogenic. |
| PubMedID- 25201910 | Rationale: diabetes mellitus increases cardiovascular disease risk in humans and remains elevated despite cholesterol-lowering therapy with statins. |
| PubMedID- 20847892 | Evidence suggests that the maintenance of a large muscle mass may reduce metabolic risk factors—namely, obesity, dyslipidaemia, and type 2 diabetes mellitus—associated with cardiovascular disease [13–15]. |
| PubMedID- 24167560 | Adjusted hrs were calculated after adjustment for age, sex, diabetes mellitus, previous history of cardiovascular disease, smoking, systolic blood pressure, the use of lipid-lowering therapy, bmi, and biochemical data (hemoglobin, albumin, ca×p products, and log hs-crp levels). |
| PubMedID- 19925460 | We present a case of brutal diabetes mellitus in a patient with severe vascular disease that underwent a third pancreas transplant. |
| PubMedID- 24465187 | The hrs were adjusted for cohort as random effect and for sex, age, body mass index, smoking, total cholesterol, diabetes mellitus, and history of cardiovascular disease as fixed effects. |
| PubMedID- 21625418 | The goal for non-hdl cholesterol has been reported to be the level of ldl cholesterol plus 30 mg/dl.36 in type 2 diabetics, several characteristics such as elevated triglycerides, decreased hdl cholesterol, and elevated small dense ldl, are well-known.25 because non-hdl cholesterol reflects all apolipoprotein b-containing atherogenic lipoproteins, non-hdl cholesterol may be useful in predicting cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26083376 | Pioglitazone has shown to have beneficial effect on cardiovascular diseases in patients with type 2 diabetes mellitus [18–20]. |
| PubMedID- 21963020 | Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited. |
| PubMedID- 25532311 | The aim of the present study was to investigate the relationship of c-peptide levels with insulin, resistance; components of metabolic syndrome and cardiovascular disease in patients with diabetes mellitus type 2. |
| PubMedID- 22285702 | We investigated the effect of rhr on the incidence of type 2 diabetes mellitus (t2dm) in patients with clinically manifest vascular diseases. |
| PubMedID- 24465050 | And, would monotherapy with either or both of those drugs reduce the risk of cardiovascular disease events in patients with type 2 diabetes mellitus? |
| PubMedID- 25612994 | We describe a concurrent manifestation of emphysematous pyelonephritis and ischaemic colitis in a 51-year-old diabetic woman and conclude that the colitis was due to pressure from a large retroperitoneal mass and sepsis complications combined with underlying peripheral vascular disease because of diabetes mellitus and hypertension. |
| PubMedID- 21108545 | Gestational diabetes mellitus and risk of future maternal cardiovascular disease. |
| PubMedID- 25708055 | This study aimed to assess the effects of active and passive smoking exposure on the development of cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25923078 | Type 2 diabetes mellitus patients with cardiovascular disease showed higher expression of plasma retinol binding protein and glutathione peroxidase-3 compared to those without cardiovascular disease and non-diabetic controls. |
| PubMedID- 20228404 | Background: we investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. |
| PubMedID- 22419928 | Cardiovascular disease in diabetes mellitus is multi-factorial and risk factors include hypertension, dyslipidaemia, insulin resistance and central obesity [8]. |
| PubMedID- 25790898 | Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomy. |
| PubMedID- 25527522 | Conclusions: in our series, type 2 diabetes mellitus patients with cardiovascular disease at baseline present with an increased risk of developing diabetic peripheral neuropathy at 10 years of follow-up. |
| PubMedID- 22228612 | Dyslipidaemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. |
| PubMedID- 25990316 | vascular disease in diabetes mellitus. |
| PubMedID- 19875998 | The impact of obesity on cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus (t2dm) and established coronary artery disease (cad) is controversial; whether bmi and/or waist circumference correlate with atherothrombotic risk factors in such patients is uncertain. |
| PubMedID- 20350283 | Despite the profound clinical importance of vascular disease in patients with diabetes mellitus, our understanding of the molecular and cellular mechanisms by which diabetes promotes these vascular complications is incomplete. |
| PubMedID- 21193740 | Rationale: diabetes mellitus is frequently complicated by cardiovascular disease, such as vascular calcification and endothelial dysfunction, which have been associated with bone morphogenetic proteins (bmps). |